It’s been said before that the American healthcare system is one giant workaround. In some areas, innovation is able to fix broken incentives and create a more sensible structure. In others, innovation means creating new workarounds; ones that improve the patient experience but fail to resolve the underlying systemic issues.
Interesting subject and analysis. Personally, I think even in either market they will still survive due to making process simpler. Would love to hear your take.
Getting an appointment for simple prescription is time consuming unless healthcare providers use telehealth or phone to make it easier. Hims actually will send prescription to nearby pharmacy and Nurx focuses on specific segment. These companies are driving market segmentation by focusing in one area coupled with best interface and customer service.
Hey Ketan! I think you may be right that they would still "survive" by incrementally improving the patient experience, but I don't think they would be the high-growth, exciting startups they are now. Plus there is already little differentiation between these companies today, and I think they would see even more competition if they were simply just another pharmacy option.
Interesting subject and analysis. Personally, I think even in either market they will still survive due to making process simpler. Would love to hear your take.
Getting an appointment for simple prescription is time consuming unless healthcare providers use telehealth or phone to make it easier. Hims actually will send prescription to nearby pharmacy and Nurx focuses on specific segment. These companies are driving market segmentation by focusing in one area coupled with best interface and customer service.
Hey Ketan! I think you may be right that they would still "survive" by incrementally improving the patient experience, but I don't think they would be the high-growth, exciting startups they are now. Plus there is already little differentiation between these companies today, and I think they would see even more competition if they were simply just another pharmacy option.